- ICH GCP
- Registro degli studi clinici negli Stati Uniti
- Search trials
Studi clinici sponsorizzati da Vascular Biogenics Ltd. operating as VBL Therapeutics
Totale 12 risultati
-
Vascular Biogenics Ltd. operating as VBL TherapeuticsCompletatoCancro ovarico resistente al platinoStati Uniti
-
Vascular Biogenics Ltd. operating as VBL TherapeuticsSconosciutoCancro d'organo solido avanzato e/o metastaticoStati Uniti
-
Vascular Biogenics Ltd. operating as VBL TherapeuticsCompletatoBiomarcatoreRegno Unito
-
Vascular Biogenics Ltd. operating as VBL TherapeuticsCompletatoSingle-Arm Open-Label Multicenter Study of VB-111 in Patients With Recurrent Glioblastoma MultiformeGlioblastoma multiformeIsraele, Stati Uniti
-
Vascular Biogenics Ltd. operating as VBL TherapeuticsCompletatoGlioblastomaStati Uniti, Israele, Canada
-
Vascular Biogenics Ltd. operating as VBL TherapeuticsCompletatoColite ulcerosaPolonia, Bulgaria, Ungheria
-
Vascular Biogenics Ltd. operating as VBL TherapeuticsCompletatoPsoriasiGermania, Israele, Polonia, Spagna
-
Vascular Biogenics Ltd. operating as VBL TherapeuticsCompletatoGrave COVID-19Israele
-
Vascular Biogenics Ltd. operating as VBL TherapeuticsCompletatoDifferential Thyroid CancerStati Uniti
-
Vascular Biogenics Ltd. operating as VBL TherapeuticsCompletatoPsoriasi a placche attivaStati Uniti, Germania, Israele
-
Vascular Biogenics Ltd. operating as VBL TherapeuticsGOG FoundationCompletatoCarcinoma ovarico resistente al platino ricorrenteStati Uniti, Israele, Giappone, Polonia, Spagna
-
Dana-Farber Cancer InstituteVascular Biogenics Ltd. operating as VBL TherapeuticsAttivo, non reclutanteGlioblastoma | Glioblastoma ricorrenteStati Uniti